Scopus BioPharma Inc.
Scopus BioPharma Inc. (SCPS) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 33 transactions totaling $148.4K, demonstrating a bullish sentiment with $148.4K in net insider flow. The most recent transaction on Aug 27, 2021 involved a purchase of 200 shares valued at $1.0K.
SCPS Insider Activity Summary
Who Is Buying SCPS Stock?
No significant insider buying has been recorded for SCPS in the recent period.
Who Is Selling SCPS Stock?
No significant insider selling has been recorded for SCPS in the recent period.
Is Scopus BioPharma Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SCPS is bullish with an Insider Alignment Score of 100/100 and a net flow of $148.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SCPS Frequently Asked Questions
Understanding SCPS Insider Activity
Insider trading at Scopus BioPharma Inc. (SCPS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading SCPS stock, having executed 33 transactions in the past 90 days. The most active insider is Ira Scott Greenspan (Executive), who has made 22 transactions totaling $122.2K.
Related Tools
Track Scopus BioPharma Inc. Insider Activity
Get notified when executives and directors at SCPS file new Form 4 transactions